Gene Expression Pattern of ESPL1, PTTG1 and PTTG1IP Can Potentially Predict Response to TKI First-Line Treatment of Patients with Newly Diagnosed CML

SIMPLE SUMMARY: There is still a lack of reliable molecular predictors to achieve major molecular response (MMR, BCR::ABL1 ≤ 0.1% IS) within the first year of treatment with tyrosine kinase inhibitors (TKI) in the therapeutic management of newly diagnosed chronic myeloid leukemia (CML). Employing a...

Descripción completa

Detalles Bibliográficos
Autores principales: Christiani, Eva, Naumann, Nicole, Weiss, Christel, Spiess, Birgit, Kleiner, Helga, Fabarius, Alice, Hofmann, Wolf-Karsten, Saussele, Susanne, Seifarth, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177117/
https://www.ncbi.nlm.nih.gov/pubmed/37174118
http://dx.doi.org/10.3390/cancers15092652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177117/
https://www.ncbi.nlm.nih.gov/pubmed/37174118
http://dx.doi.org/10.3390/cancers15092652

Ejemplares similares